Teladoc Health vs Tempus AI
Teladoc Health is the larger business, with $2.53bn of revenue in fiscal 2025 against $1.27bn for Tempus AI (2.0 times as much). Tempus AI grew faster (83.4% against -1.5%). Teladoc Health kept more of each dollar of sales as profit: a net margin of -7.9% against -19.3%.
| Latest fiscal year | Teladoc HealthTDOC, 2025 | Tempus AITEM, 2025 |
|---|---|---|
| Revenue | $2.53bn | $1.27bn |
| Revenue growth | -1.5% | 83.4% |
| Net income | −$200m | −$245m |
| Operating margin | — | -19.9% |
| Net margin | -7.9% | -19.3% |
| Return on equity | -13.9% | -89.5% |
| Free cash flow | $285m | −$239m |
| Cash | $781m | $605m |
| Total debt | $995m | $209m |
| Debt to equity | — | 42.5% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | $3.0m |
| Employees | 5,600 | 3,800 |
| Market value | $1.62bn | $14.29bn |
| Price vs our value range | Below our value range | — |
| Moat score | 36 (Weak) | — |
| Insider trades, 12 months | 1 buys, 37 sales | 12 buys, 247 sales |